Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. View on euronews ...

A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast ...

University of Pennsylvania researchers say an analysis of more than 110,000 women ages 45-80 revealed GLP-1 users were 30 ...

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic improvements associated with this class of medications.

WEIGHT loss jabs could soon be used to fight cancer as research suggests they can prevent and treat the disease. A number of ...

Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...

A large retrospective study published today analyzed over 100,000 women and observed that those on GLP-1s were up to 35% less likely to develop breast cancer. Experts say the link may be driven by ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...

Researchers from Trinity College Dublin, St James's Hospital, and collaborating institutions have carried out the most ...

We found four breast cancer risk prediction models that had been tested enough times to evaluate in detail. These were the Gail, Tyrer-Cuzick, BOADICEA, and BRCAPRO models. The BOADICEA model was one ...

For children assigned female at birth, the first sign of puberty is usually the development of breasts. While this milestone can be exciting, it can also be filled with many questions and concerns—for ...